Anling Biotech
安龄生物
Anling Biotech
Biotech/Healthcare
Anling Bio is a clinical-stage biopharmaceutical company dedicated to developing novel approaches through the de novo discovery of exosomes—'naturally domesticated' biomolecular drug carriers—which are engineered to enable new drug development and transform conventional drug delivery methods in…
Latest round: Series A (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.